Immunocore

NASDAQ: IMCR · Real-Time Price · USD
32.94
-0.12 (-0.36%)
At close: Aug 15, 2025, 3:59 PM
32.88
-0.17%
After-hours: Aug 15, 2025, 04:10 PM EDT

Immunocore Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
455.73M 442.63M 332.54M 237.89M
Short-Term Investments
364.64M n/a n/a n/a
Long-Term Investments
n/a n/a 137K 4.93M
Other Long-Term Assets
17.12M 14.47M 7.21M -31.54M
Receivables
83.1M 61.44M 27.78M 24.84M
Inventory
5.45M 4.5M 943K -18.79M
Other Current Assets
7.9M 9.71M 3.62M 18.79M
Total Current Assets
929.86M 528.82M 391.88M 262.73M
Property-Plant & Equipment
47.73M 42.73M 31.64M 31.54M
Goodwill & Intangibles
n/a n/a 410K 31.54M
Total Long-Term Assets
79.64M 68.18M 43.64M 39.05M
Total Assets
1.01B 597M 435.52M 301.77M
Account Payables
25.1M 17.8M 14.45M 10.12M
Deferred Revenue
n/a n/a 6.41M 24.45M
Short-Term Debt
n/a n/a -17.75M 8.59M
Other Current Liabilities
13.1M 11.6M -8.6M 8.63M
Total Current Liabilities
212.18M 139.02M 83.09M 61.18M
Long-Term Debt
391.01M 48.01M n/a 50.24M
Other Long-Term Liabilities
45.6M 978K 36.67M 8.73M
Total Long-Term Liabilities
436.61M 89.14M 73.67M 69.05M
Total Liabilities
648.79M 228.16M 156.76M 130.23M
Total Debt
432.72M 84.03M 69.3M 63.84M
Common Stock
135K 105.11K 97K 88K
Retained Earnings
-795.76M -744.67M -261.25M -481.39M
Comprehensive Income
-33.76M -36.26M 334.75M 386.26M
Shareholders Equity
360.72M 368.84M 278.76M 171.55M
Total Investments
364.64M n/a 137K 4.93M